LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis.

Yiran LiangXiaojin SongYaming LiBing ChenWenjing ZhaoLijuan WangHanwen ZhangYing LiuDianwen HanNing ZhangTingting MaYajie WangFangzhou YeDan LuoXiaoyan LiQifeng Yang

Published in: Molecular cancer (2020)

Collectively, these results reveal a novel HIF-1α/lncRNA BCRT1/miR-1303/PTBP3 pathway for breast cancer progression and suggest that lncRNA BCRT1 might be a potential biomarker and therapeutic target for breast cancer.

Keyphrases

long non coding rna
long noncoding rna
cell proliferation
single cell
dna methylation
breast cancer risk